Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601793 | 1.00 | ALDH1A1 (0.36) | ALDH1A1MAPTMEN1KMT2APLA2G2A | |
| SCHEMBL24601328 | 0.93 | ALDH1A1 (0.32) | ALDH1A1MAPTALOX5 | |
| SCHEMBL24601601 | 0.93 | ALDH1A1 (0.32) | ALDH1A1MAPTALOX5 | |
| SCHEMBL24601796 | 0.89 | PLA2G2A (0.39) | PLA2G2APLA2G4AALOX5 | |
| SCHEMBL24601794 | 0.89 | PLA2G2A (0.39) | PLA2G2APLA2G4AALOX5 | |
| SCHEMBL24601410 | 0.89 | ALOX5 (0.36) | ALDH1A1MAPTMEN1KMT2APLA2G2A | |
| SCHEMBL24601604 | 0.89 | ALDH1A1 (0.34) | ALDH1A1MAPTALOX5 | |
| SCHEMBL24601324 | 0.89 | ALDH1A1 (0.34) | ALDH1A1MAPTPLA2G2APLA2G4AALOX5 | |
| SCHEMBL22178596 | 0.84 | ALOX5 (0.38) | ALDH1A1MAPTPLA2G2APLA2G4AALOX5 | |
| SCHEMBL22178726 | 0.84 | ALOX5 (0.38) | ALDH1A1MAPTMEN1KMT2APLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NOC2L, NOLC1 | ALDH1A1 3824/4885MAPT 1370/4885MEN1 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.